Author
R. Todd Stravitz
Other affiliations: University of Texas Southwestern Medical Center, VCU Medical Center
Bio: R. Todd Stravitz is an academic researcher from Virginia Commonwealth University. The author has contributed to research in topics: Liver transplantation & Liver disease. The author has an hindex of 50, co-authored 139 publications receiving 9397 citations. Previous affiliations of R. Todd Stravitz include University of Texas Southwestern Medical Center & VCU Medical Center.
Papers published on a yearly basis
Papers
More filters
University of Texas Southwestern Medical Center1, University of California, Davis2, University of Michigan3, Virginia Commonwealth University4, University of Washington5, University of California, San Francisco6, Baylor University Medical Center7, University of Nebraska Omaha8, National Institutes of Health9
TL;DR: Intravenous NAC improves transplant-free survival in patients with early stage non-acetaminophen-related acute liver failure and typically require emergency liver transplantation.
529 citations
TL;DR: Modifying MELD, by including points for persistent ascites and low serum sodium, improved prediction of early pretransplant mortality in low MELD score patients, and should be considered in setting minimal listing criteria.
484 citations
TL;DR: A combination of vitamin E and pioglitazone produces a greater improvement in NASH histology, and the improvement in steatosis and cytologic ballooning are related to treatment-associated decreases in fasting FFA and insulin levels.
422 citations
TL;DR: Fulminant Wilson's disease can be diagnosed most effectively not by waiting for copper levels (too slow to obtain) or by obtaining ceruloplasmin levels (low in half of all ALF patients, regardless of etiology), but by simply looking for the more readily available bilirubin level and alkaline phosphatase (ALP; very low).
390 citations
Virginia Commonwealth University1, University of Calgary2, University of California, San Francisco3, University of Pittsburgh4, University of Virginia5, University of California, San Diego6, Northwestern University7, University of Michigan8, University of Alabama9, University of California, Davis10, Duke University11
TL;DR: Recommendations encompassing specific hematologic, renal, pulmonary, and endocrine complications of acute liver failure patients are provided, including their management during and after orthotopic liver transplantation.
Abstract: Objective:To provide a uniform platform from which to study acute liver failure, the U.S. Acute Liver Failure Study Group has sought to standardize the management of patients with acute liver failure within participating centers.Methods:In areas where consensus could not be reached because of diverg
340 citations
Cited by
More filters
TL;DR: This guidance provides a data-supported approach to the diagnostic, therapeutic, and preventive aspects of NAFLD care.
4,431 citations
TL;DR: This is a practice guideline for clinicians rather than a review article and interested readers can refer to several comprehensive reviews published recently.
3,212 citations
TL;DR: In conclusion, noninvasive tests can accurately predict hepatic fibrosis and may reduce the need for liver biopsy in the majority of HIV/HCV‐coinfected patients.
3,183 citations
TL;DR: This document has been approved by the AASLD, the Infectious Diseases Society of America, and the American College of Gastroenterology.
3,013 citations
TL;DR: Aliment Pharmacol Ther 2011; 34: 274–285
Abstract: SUMMARY Background Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease, and its worldwide prevalence continues to increase with the growing obesity epidemic. This study assesses the epidemiology of NAFLD in adults based on clinical literature published over the past 30 years. Aim To review epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults based on clinical literature published over the past 30 years. Methods An in-depth search of PubMed (1980–2010) was based on five search terms: ‘nonalcoholic fatty liver disease’ OR ‘non-alcoholic steatohepatitis’ OR ‘fatty liver’ OR ‘steatosis’ AND ‘incidence’ [MeSH Terms] OR ‘prevalence’ [MeSH Terms] OR ‘natural history’. Studies of paediatric cohorts were excluded. Articles were categorised by topic and summarised, noting generalisations concerning their content.
2,679 citations